Filing Details
- Accession Number:
- 0001209191-17-014077
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-23 20:23:32
- Reporting Period:
- 2017-02-21
- Filing Date:
- 2017-02-23
- Accepted Time:
- 2017-02-23 20:23:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1513818 | Versartis Inc. | VSAR | Pharmaceutical Preparations (2834) | 264106690 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587788 | Jay Shepard | C/O Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park CA 94025 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-21 | 8,000 | $2.53 | 221,858 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-21 | 8,000 | $18.50 | 213,858 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-02-23 | 8,000 | $2.53 | 221,858 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-23 | 8,000 | $20.00 | 213,858 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-21 | 8,000 | $0.00 | 8,000 | $2.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-02-23 | 8,000 | $0.00 | 8,000 | $2.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,994 | 2023-12-27 | No | 4 | M | Direct | |
| 70,994 | 2023-12-27 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to 10b5-1 plan.
- 25% of the shares subject to the option become exercisable one year from 12/10/2013; the remainder become exercisable in equal monthly installments over the following three years.
Billionaire Hedge Funds
